These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 2154669)

  • 1. Identification, characterization, and photoaffinity labeling of the dihydropyridine receptor associated with the L-type calcium channel from bovine adrenal medulla.
    Murphy BJ; Rogers CA; Sunahara RK; Lemaire S; Tuana BS
    Mol Pharmacol; 1990 Feb; 37(2):173-81. PubMed ID: 2154669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium ions inhibit the allosteric interaction between the dihydropyridine and phenylalkylamine binding site on the voltage-gated calcium channel in heart sarcolemma but not in skeletal muscle transverse tubules.
    Murphy BJ; Tuana BS
    Can J Physiol Pharmacol; 1990 Nov; 68(11):1389-95. PubMed ID: 1962734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of the dihydropyridine calcium channel blocker (+)-[3H] isopropyl-4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-5-methoxycarbonyl-2, 6-dimethyl-3-pyridinecarboxylate (PN200-110) to RINm5F membranes and cells: characterization and functional significance.
    Yaney GC; Stafford GA; Henstenberg JD; Sharp GW; Weiland GA
    J Pharmacol Exp Ther; 1991 Aug; 258(2):652-62. PubMed ID: 1713965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of the dihydropyridine-binding subunit of the skeletal muscle dihydropyridine receptor.
    Sharp AH; Imagawa T; Leung AT; Campbell KP
    J Biol Chem; 1987 Sep; 262(25):12309-15. PubMed ID: 3040737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (+)-PN200-110 and ouabain binding sites in purified bovine adrenomedullary plasma membranes and chromaffin cells.
    Castillo CJ; Fonteríz RI; López MG; Rosenheck K; García AG
    J Neurochem; 1989 Nov; 53(5):1442-9. PubMed ID: 2529351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydropyridine receptor of L-type Ca2+ channels: identification of binding domains for [3H](+)-PN200-110 and [3H]azidopine within the alpha 1 subunit.
    Striessnig J; Murphy BJ; Catterall WA
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10769-73. PubMed ID: 1660150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding Ca2+ to intracellular or to extracellular sites of dihydropyridine receptor of rabbit skeletal muscle discriminates between in vitro binding of Ca2+-channel agonist and antagonist.
    Kanngiesser U; Pongs O
    Eur J Biochem; 1989 May; 181(2):467-73. PubMed ID: 2540975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of 1,4, dihydropyridine calcium channel binding sites in the human prostate.
    Rosenthal E; Shapiro E; Lepor H
    J Urol; 1990 Dec; 144(6):1539-42. PubMed ID: 1700163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is Ca2+ antagonists binding protein from cytosolic fraction the precursor of alpha 1-subunit of Ca2+ channel?
    Krizanová O; Hudecová S; Orlický J; Zachar J
    Gen Physiol Biophys; 1989 Apr; 8(2):99-111. PubMed ID: 2550315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3H]HOE166 defines a novel calcium antagonist drug receptor--distinct from the 1,4 dihydropyridine binding domain.
    Grassegger A; Striessnig J; Weiler M; Knaus HG; Glossmann H
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec; 340(6 Pt 2):752-9. PubMed ID: 2561307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SR33557, an indolizinsulfone blocker of Ca2+ channels: identification of receptor sites and analysis of its mode of action.
    Schmid A; Romey G; Barhanin J; Lazdunski M
    Mol Pharmacol; 1989 Jun; 35(6):766-73. PubMed ID: 2543910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydropyridine-sensitive Ca2+ channels: molecular properties of interaction with Ca2+ channel blockers, purification, subunit structure, and differentiation.
    Lazdunski M; Barhanin J; Borsotto M; Fosset M; Galizzi JP; Renaud JF; Romey G; Schmid A
    J Cardiovasc Pharmacol; 1986; 8 Suppl 8():S13-9. PubMed ID: 2433514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive heterotropic allosteric regulators of dihydropyridine binding increase the Ca2+ affinity of the L-type Ca2+ channel. Stereoselective reversal by the novel Ca2+ antagonist BM 20.1140.
    Staudinger R; Knaus HG; Glossmann H
    J Biol Chem; 1991 Jun; 266(17):10787-95. PubMed ID: 1645709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photoaffinity labeling of the calcium channel antagonist receptor in the heart of the cardiomyopathic hamster.
    Kuo TH; Johnson DF; Tsang W; Wiener J
    Biochem Biophys Res Commun; 1987 Nov; 148(3):926-33. PubMed ID: 2446613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]PN200-110 binding in a fibroblast cell line transformed with the alpha 1 subunit of the skeletal muscle L-type Ca2+ channel.
    Rampe D; Kim HS; Lacerda AE; Birnbaumer L; Brown AM
    Biochem Biophys Res Commun; 1990 Jun; 169(3):825-31. PubMed ID: 2163635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Separate [3H]-nitrendipine binding sites in mitochondria and plasma membranes of bovine adrenal medulla.
    Ballesta JJ; Garcia AG; Gutierrez LM; Hidalgo MJ; Palmero M; Reig JA; Viniegra S
    Br J Pharmacol; 1990 Sep; 101(1):21-6. PubMed ID: 1704272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of binding of dihydropyridine calcium channel ligands to skeletal muscle membranes: evidence for low-affinity sites and for the involvement of G proteins.
    Dunn SM; Bladen C
    Biochemistry; 1991 Jun; 30(23):5716-21. PubMed ID: 1645998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subunit composition is a major determinant in high affinity binding of a Ca2+ channel blocker.
    Suh-Kim H; Wei X; Birnbaumer L
    Mol Pharmacol; 1996 Nov; 50(5):1330-7. PubMed ID: 8913365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photoaffinity-labelling of the calcium-channel-associated 1,4-dihydropyridine and phenylalkylamine receptor in guinea-pig hippocampus. A 195 kDa polypeptide carries both drug receptors and has similarities to the alpha 1 subunit of the purified skeletal-muscle calcium channel.
    Striessnig J; Knaus HG; Glossmann H
    Biochem J; 1988 Jul; 253(1):39-47. PubMed ID: 2844171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereoselective photoaffinity labelling of the purified 1,4-dihydropyridine receptor of the voltage-dependent calcium channel.
    Striessnig J; Moosburger K; Goll A; Ferry DR; Glossmann H
    Eur J Biochem; 1986 Dec; 161(3):603-9. PubMed ID: 2431906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.